These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 15607562)

  • 21. High-dose azithromycin or amoxicillin-clavulanate for recurrent otitis media?
    Ables AZ; Warren PK
    J Fam Pract; 2004 Mar; 53(3):186-8. PubMed ID: 15000920
    [No Abstract]   [Full Text] [Related]  

  • 22. Amoxicillin-clavulanate ineffective for suspected acute sinusitis.
    Jackson EA
    J Fam Pract; 2003 Dec; 52(12):930-2. PubMed ID: 14653975
    [No Abstract]   [Full Text] [Related]  

  • 23. Development of a twice daily dosing regimen of amoxicillin/clavulanate.
    Bax R
    Int J Antimicrob Agents; 2007 Dec; 30 Suppl 2():S118-21. PubMed ID: 17983732
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Current recommendations on the therapy of otitis media.
    Klein JO
    Pediatr Infect Dis J; 1998 Nov; 17(11):1058-9. PubMed ID: 9849999
    [No Abstract]   [Full Text] [Related]  

  • 25. [Antibiotics in therapy of bacterially infected diabetic foot. Results in 191 patients].
    Schiewe U; Gerards HH
    MMW Fortschr Med; 1999 Dec; 141(49-50):42. PubMed ID: 10726146
    [No Abstract]   [Full Text] [Related]  

  • 26. Efficacy and safety of twice-daily pharmacokinetically enhanced amoxicillin/clavulanate (2000/125 mg) in the treatment of adults with community-acquired pneumonia in a country with a high prevalence of penicillin-resistant Streptococcus pneumoniae.
    Siquier B; Sánchez-Alvarez J; García-Mendez E; Sabriá M; Santos J; Pallarés R; Twynholm M; Dal-Ré R;
    J Antimicrob Chemother; 2006 Mar; 57(3):536-45. PubMed ID: 16446376
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Case report: Otitis due to Vibrio alginolyticus].
    Ardiç N; Ozyurt M
    Mikrobiyol Bul; 2004; 38(1-2):145-8. PubMed ID: 15293914
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy of cefditoren pivoxil and amoxicillin/clavulanate in the treatment of pediatric patients with acute bacterial rhinosinusitis in Thailand: a randomized, investigator-blinded, controlled trial.
    Poachanukoon O; Kitcharoensakkul M
    Clin Ther; 2008 Oct; 30(10):1870-9. PubMed ID: 19014842
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Bacterial flora in children with recurrent acute otitis media].
    Zielnik-Jurkiewicz B; Kolczyńska M
    Pol Merkur Lekarski; 2005 Feb; 18(104):146-50. PubMed ID: 17877118
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Broad-spectrum antibiotics in ORACLE.
    Ginath S; Malinger G; Sadan O; Glezerman M
    Lancet; 2001 Aug; 358(9280):502-3; author reply 503-4. PubMed ID: 11515506
    [No Abstract]   [Full Text] [Related]  

  • 31. Mental health in the United States: parental report of diagnosed autism in children aged 4-17 years--United States, 2003-2004.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2006 May; 55(17):481-6. PubMed ID: 16675944
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparative study of levofloxacin in the treatment of children with community-acquired pneumonia.
    Bradley JS; Arguedas A; Blumer JL; Sáez-Llorens X; Melkote R; Noel GJ
    Pediatr Infect Dis J; 2007 Oct; 26(10):868-78. PubMed ID: 17901791
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Autism, epilepsy and mitochondrial disease: points of contact].
    García-Peñas JJ
    Rev Neurol; 2008; 46 Suppl 1():S79-85. PubMed ID: 18302129
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Augmentin-associated jaundice.
    Thomson JA; Fairley CK; McNeil JJ; Purcell P
    Med J Aust; 1994 Jun; 160(11):733-4. PubMed ID: 8202020
    [No Abstract]   [Full Text] [Related]  

  • 35. Drug eruptions in children with ENT infections.
    Rallis E; Balatsouras DG; Kouskoukis C; Verros C; Homsioglou E
    Int J Pediatr Otorhinolaryngol; 2006 Jan; 70(1):53-7. PubMed ID: 15978677
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Adverse drug reactions related to amoxicillin alone and in association with clavulanic acid: data from spontaneous reporting in Italy.
    Salvo F; Polimeni G; Moretti U; Conforti A; Leone R; Leoni O; Motola D; Dusi G; Caputi AP
    J Antimicrob Chemother; 2007 Jul; 60(1):121-6. PubMed ID: 17449881
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The clinical development and launch of amoxicillin/clavulanate for the treatment of a range of community-acquired infections.
    Ball P
    Int J Antimicrob Agents; 2007 Dec; 30 Suppl 2():S113-7. PubMed ID: 17997283
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Acute otitis media: making sense of recent guidelines on antimicrobial treatment.
    Pichichero ME; Casey JR
    J Fam Pract; 2005 Apr; 54(4):313-22. PubMed ID: 15833221
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Broad-spectrum antibiotics in ORACLE.
    Wilcox M; Hoy C
    Lancet; 2001 Aug; 358(9280):503; author reply 503-4. PubMed ID: 11515509
    [No Abstract]   [Full Text] [Related]  

  • 40. A new approach to treating acute otitis media.
    Montgomery D
    J Pediatr Health Care; 2005; 19(1):50-2. PubMed ID: 15662363
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.